<DOC>
	<DOCNO>NCT00926315</DOCNO>
	<brief_summary>The purpose study evaluate whether calcitriol supplementation may reduce tumor cell proliferation influence gene expression profile breast cancer sample post-menopausal patient .</brief_summary>
	<brief_title>Gene Expression Profile Breast Cancer Samples After Vitamin D Supplementation</brief_title>
	<detailed_description>Women affect breast cancer present low 1,25 ( OH ) 2D3 25 ( OH ) D3 serum level unaffected one . Calcitriol supplementation may indicate post-menopausal woman reduce bone loss . Vitamin D antiproliferative effect breast cancer cell line breast cancer xenograft . Post-menopausal breast cancer patient prescribe calcitriol supplementation , dos indicate prevent osteoporosis , submit biopsy , stag exam breast surgery schedule ( approximately one month ) . Tumor dimension proliferation rate ( determine Ki67 expression ) , 25 ( OH ) D3 and/or 1,25 ( OH ) 2D3 serum concentration , evaluate calcitriol supplementation . Tumor gene expression evaluate sample collect supplementation analyze differential profile .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Postmenopausal woman Invasive breast carcinoma Clinical condition breast surgery No previous neoadjuvant treatment breast cancer Agreement take part study sign inform consent History hypercalcemia nephrolithiasis Current use corticosteroid , vitamin D supplementation , HRT Previous chemotherapy , hormonotherapy radiotherapy Parathyroid disease Absence clinical condition receive supplementation</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Breast Neoplasms</keyword>
	<keyword>Calcitriol</keyword>
	<keyword>Postmenopausal</keyword>
	<keyword>Cell Proliferation</keyword>
	<keyword>Gene Expression Profiling</keyword>
</DOC>